We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
(+1.1%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-9.07%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XP
XP
|
+$7.27M |
| 2 |
Constellation Brands
STZ
|
+$7.01M |
| 3 |
Eli Lilly
LLY
|
+$6.9M |
| 4 |
Automatic Data Processing
ADP
|
+$6.79M |
| 5 |
Nu Holdings
NU
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$11.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.9M |
| 3 |
Microsoft
MSFT
|
+$11.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$11.7M |
| 5 |
Las Vegas Sands
LVS
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 18.49% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Industrials | 10.31% |
| 5 | Financials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Arrowhead Research
ARWR
$12.2B
| $333K | 0.04% |
10,866
-13,608
| -56% | -$361K |
|
502
FormFactor
FORM
$9.12B
| $332K | 0.04% |
+7,970
| New | +$292K |
|
|
CWAN
503
DELISTED
Clearwater Analytics
CWAN
| $332K | 0.04% |
+16,573
| New | +$326K |
|
504
Camping World
CWH
$672M
| $331K | 0.04% |
12,601
-8,249
| -40% | -$173K |
|
505
Green Plains
GPRE
$1.18B
| $329K | 0.04% |
13,028
+4,849
| +59% | +$128K |
|
506
HCA Healthcare
HCA
$86.2B
| $328K | 0.04% |
1,213
-3,319
| -73% | -$820K |
|
507
Armstrong World Industries
AWI
$7.63B
| $326K | 0.04% |
+3,312
| New | +$274K |
|
508
Viper Energy
VNOM
$8.3B
| $320K | 0.04% |
+10,207
| New | +$303K |
|
509
McCormick & Company Non-Voting
MKC
$13.7B
| $319K | 0.04% |
4,668
-16,878
| -78% | -$1.1M |
|
510
Zscaler
ZS
$25.9B
| $318K | 0.04% |
+1,435
| New | +$266K |
|
511
Chipotle Mexican Grill
CMG
$47B
| $316K | 0.04% |
6,900
-71,350
| -91% | -$2.97M |
|
|
SQSP
512
DELISTED
Squarespace, Inc.
SQSP
| $315K | 0.04% |
+9,551
| New | +$280K |
|
513
Semtech
SMTC
$11.8B
| $314K | 0.04% |
14,349
+3,726
| +35% | +$69.1K |
|
514
Primerica
PRI
$9.88B
| $314K | 0.04% |
+1,525
| New | +$312K |
|
515
Louisiana-Pacific
LPX
$5.23B
| $308K | 0.04% |
4,349
-11,045
| -72% | -$660K |
|
516
Doximity
DOCS
$3.95B
| $304K | 0.04% |
+10,835
| New | +$256K |
|
517
Old Dominion Freight Line
ODFL
$44.5B
| $304K | 0.04% |
1,498
+102
| +7% | +$20.2K |
|
518
Cemex
CX
$16.9B
| $300K | 0.03% |
38,725
+919
| +2% | +$6.25K |
|
519
Jack Henry & Associates
JKHY
$11.1B
| $300K | 0.03% |
+1,835
| New | +$281K |
|
520
Idexx Laboratories
IDXX
$47.1B
| $296K | 0.03% |
534
-721
| -57% | -$338K |
|
521
HEICO Corp Class A
HEI.A
$37B
| $289K | 0.03% |
2,026
-1,066
| -34% | -$144K |
|
522
SiTime
SITM
$17.4B
| $288K | 0.03% |
+2,363
| New | +$268K |
|
523
Allegiant Air
ALGT
$2.87B
| $287K | 0.03% |
+3,474
| New | +$251K |
|
|
VERV
524
DELISTED
Verve Therapeutics
VERV
| $287K | 0.03% |
+20,562
| New | +$255K |
|
525
NXP Semiconductors
NXPI
$58.9B
| $285K | 0.03% |
+1,243
| New | +$250K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.
- Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
- Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
- Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
- Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
- Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
- Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
- Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.
Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.